<div class="sc-type-small">
<div>
<p>Dr Tim Karl and his team at NeuRA are investigating a component in the cannabis plant called cannabidiol or CBD. CBD is thought to reduce the psychoactive effects of the most well-known component of cannabis, THC.</p>
<p>The team has also found that CBD may be effective in treating Alzheimer’s disease. In a recent study, when mice were given CBD, they showed drastic improvements on memory related tests.</p>
</div>
</div>

Dr Tim Karl and his team at NeuRA are investigating a component in the cannabis plant called cannabidiol or CBD. CBD is thought to reduce the psychoactive effects of the most well-known component of cannabis, THC. The team has also found that CBD may be effective in treating Alzheimer’s disease. In a recent study, when mice were given CBD, they showed drastic improvements on memory related tests.



<p>Dr Tim Karl and his team at NeuRA are investigating a component in the cannabis plant called cannabidiol or CBD. CBD is thought to reduce the psychoactive effects of the most well-known component of cannabis, THC.</p>
<p>The team has also found that CBD may be effective in treating Alzheimer’s disease. In a recent study, when mice were given CBD, they showed drastic improvements on memory related tests.</p>



Episode 15: Cannabis has antipsychotic properties and could stop neurodegeneration in Alzheimer’s disease

Our podcasts, recorded in the NeuRA Studio, take you behind the scenes at NeuRA through interviews with our researchers and news from the world of medical and clinical research. They highlight cutting-edge research, general health information and innovative programs.

Share NeuRA Podcasts

Sign up to save your podcasts

NeuRA Podcasts

NeuRA Podcasts episodes

About NeuRA Podcasts